This was the pinned tweet on my previous account, the one that was hacked. This will forever be the pinned tweet on my new account 💪🏼 I had a dream, it is now my reality 🙏🏼

FDA Approves First Cellular Therapy to Treat Patients with Severe Aplastic Anemia | FDA #ASH25

#ASH25 #mmsm @ASH_hematology #ASHKudos @rajshekharucms for 2 oral presentations likely to change future of AL amyloidosis care

Stir up the group chat with a "let’s go to Florida this weekend 😎”

Not practice changing, but hard to ignore! Aza-Ven gets patients to CR/CRc with far less toxicity, and is more realistic in LMIC/community settings. IC arm also received Vyxeos and seems to have more p53 mutated patients, so the comparison is not clean. Still, the signal is

I couldn’t go to #ASH25 this year but my feed page has kept me updated .. amazing work and engagement from everyone

My entire feed is filled with content from #ASH25 and I'm loving it 💪🏽 The volume and quality of the data being presented is remarkable! #Hematology is really incredible ❤️

Get clear, healthy-looking nails with podiatrist recommended NONYX. NONYX is clinically proven for fungus damaged and discolored, thick, brittle, yellow and lifted nails. 90% of nails improve using NONYX. So effective its money-back guaranteed.

h ASH tagged!.. Here’s to more collabor-ASH-ions ahead! Great meeting up with @Vikas_Gupta_1 and @BipinSavani #ASH25 @HCC_HemeCancer @ASH_hematology

Aza+Ven >>> IC for select ND-AML 💪🏽 The goal is to get into CR and consolidate with allo. Allo works best if you are fit enough to survive it! Aza-ven gets you there in better shape 💪🏽 Congratulations to Dr. Fathi et al 🙌🏽 #ASH25

CONGRESS | #ASH25 | PRESENTATION Amir Fathi presents results of the phase II PARADIGM trial comparing conventional induction chemotherapy (IC; n = 86) vs Aza + Ven (n = 86) in functionally fit patients with untreated #AML. After a median FU of 21.9 months, median EFS was 14.6

Aza+Ven >>> IC for select ND-AML 💪🏽 The goal is to get into CR and consolidate with allo. Allo works best if you are fit enough to survive it! Aza-ven gets you there in better shape 💪🏽 Congratulations to Dr. Fathi et al 🙌🏽 #ASH25

Trump says NEWSMAX is 'terrific!' Click below to find out why...

#ASH25 #ASHPlenary #PARADIGM trial Great work, congratulations to Dr. Fathi and colleagues! #AML #leusm Summary: The study met PE for EFS. Higher ORR and CR in VEN+AZA gp More pt received transplant in VEN+AZA gp Better QOL

🙏🏽 Anyone who wants to learn more about this legend should read “Living Medicine” by Prof. Appelbaum 🙏🏽 #ASH25

Just legend🙏 #ASH25 @ASH_hematology

A tremendous and well-deserved standing ovation for Dr. Rainer Storb of @fredhutch — a founding architect of allogeneic bone marrow transplantation and mentor to generations — receiving the Wallace H. Coulter Award for Lifetime Achievement in Hematology at #ASH25.

Your Jeep deserves more than just a traditional lift kit — it deserves an AccuAir Dynamic Lift Kit. Follow for updates.

#ASH25 IV iron in hospitalized patients with iron-deficiency anemia and active infection seems to be safe and doesn’t worsen survival.

Aza-Ven should be the standard in LMICs where 7+3 is way more toxic #ASH25 #Leusm

I miss being at #ASH25 in sunny Orlando!

Toronto this morning ❤️

Coming December 9 at 8:00 AM PT, our last Microsoft Research Forum episode of the year.  Register now:

💪🏽💪🏽💪🏽💪🏽💪🏽💪🏽💪🏽💪🏽💪🏽💪🏽💪🏽💪🏽💪🏽💪🏽💪🏽

Not sure why so many #MPNsm trials at #ASH25 are now reporting SVR25 instead of SVR35 (ie the proportion of patients with 25% or greater spleen volume reduction, instead of 35%, which has been used for many years and was the basis for several drug approvals.) Lowering the

.@NicoGagelmann shares findings that longer telomeres in donors ≥35 are associated with reduced graft failure and lower non-relapse mortality following allogeneic HCT. #ASH25